3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Colorectal Neoplasms
2
Uterine Neoplasms
1
Recurrence
1
Neoplasms
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Advanced Cancer
1
Interventions
Carboplatin
7
Pemetrexed
5
pembrolizumab
4
Gemcitabine
4
osimertinib
3
Sorafenib
3
Paclitaxel
3
Interleukin-2
3
Cyclophosphamide
3
Cisplatin
3
seocalcitol
2
selinexor
2
patritumab
2
liposomal doxorubicin
2
interferon gamma-1b
2
fludarabine
2
Sunitinib
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Irinotecan
2
Erlotinib Hydrochloride
2
DNA
2
Celecoxib
2
Capecitabine
2
Bleomycin
2
Bevacizumab
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
volociximab
1
thioredoxin reductase inhibitor AM12
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Carcinoma
×
gedatolisib
×
Clear all
NCT02920450
2019-10-04
UF-STO-LUNG-002
University of Florida
Phase 1/2
Terminated
3 enrolled
8 charts